TNB Tech Minute: Allbirds Stock Takes Flight with AI Pivot
WSJ Tech News Briefing
The Wall Street Journal
4.3 • 1.7K Ratings
🗓️ 15 April 2026
⏱️ 3 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | I think the potential of Agenic is to rethink how work gets done overall. |
| 0:05.0 | It challenges all sorts of traditional orthodoxies around how organizations execute the work at hand. |
| 0:11.3 | That's Jason Gersatus, CEO of Deloitte U.S., talking about the transformational potential of A.Gentic AI. |
| 0:17.9 | Join him later to learn why agents are a game changer for businesses across industries. |
| 0:24.5 | Here's your afternoon, TNB Tech Minute, for Wednesday, April 15th. I'm Julie Chang for the Wall |
| 0:30.5 | Street Journal. The company that once made Tech Bros.'s favorite shoes is joining the tech industry. |
| 0:36.9 | Allbirds announced today that it's changing |
| 0:38.7 | its name to New Bird AI, as it looks to capitalize on the AI frenzy by buying and renting out |
| 0:44.7 | high-end servers equipped with AI chips. The move comes just weeks after Allbirds struck a deal to |
| 0:50.4 | sell most of his assets for $39 million. It was once valued at $4 billion. The company announced |
| 0:57.7 | that it was raising $50 million for its AI pivot, sending its stock soaring. Still, even with Wednesday's |
| 1:04.2 | gain of about 600%, shares are down more than 90% from its 2021 IPO. |
| 1:16.7 | ASML holding raised its sales guidance for the year as chipmakers scramble to secure its semiconductor making machines to turn out increasingly advanced AI chips. The Dutch group counts |
| 1:22.2 | TSMC, Samsung electronics, and Intel among its largest clients, and has been a key beneficiary of the |
| 1:28.6 | AI boom. ASML CEO noted that chip demand is outstripping supply, leading customers to |
| 1:34.6 | accelerate capacity expansion. ASML now anticipates sales between about $42.5 to $47.2 billion |
| 1:42.0 | for the year. Its stock has more than doubled over the last year. |
| 1:46.8 | Finally, Amazon is launching Amazon Bio Discovery, a new app to help research organizations scale |
| 1:53.2 | Lab in the Loop drug discovery. Lab in the Loop uses AI-powered predictions that improve with |
| 1:58.7 | experimental lab feedback. While the process has transformed research for some organizations, others have struggled to scale it. |
| 2:06.3 | Amazon says the app aims to scale lab-in-the-loop by bringing computational design and wet-lab |
| 2:11.1 | validation together in one application with access to more than 40 AI biology models with |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

